Pharmafile Logo
Pharmafocus logo
Advanced Search

oncology

Showing 15 posts of 322 posts found.

Jazz Pharmaceuticals to acquire Celator in $1.5 billion deal

May 31, 2016
Manufacturing and Production, Sales and Marketing $1.5 billion, Vyxeos, acquisition, celator, jazz, leukaemia, merger, oncology

Jazz Pharmaceuticals (NASDAQ: JAZZ) has announced that it has entered into a definitive merger agreement with Celator Pharmaceuticals (NASDAQ: CPXX) …

News
needles

BTG acquires promising oncology pipeline in Galil Medical takeover

May 9, 2016
Manufacturing and Production, Research and Development, Sales and Marketing $84 million, BTG, cryoablation, galil medical, oncology, takeover

BTG (LSE: BTG) has announced that is has agreed to acquire Galil Medical, a leading provider of cryoablation products for …

News
tug-of-war

Focus: Medivation tug-of-war rumbles on

May 6, 2016
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Amgen, AstraZeneca, Medivation, Pfizer, Sanofi, billion dollar, competition, oncology, pipeline, promising, takeover, tug of war

Medivation (NASDAQ: MDVN) has been making all the headlines as a list of suitors’ line up, all vying to secure …

Feature
2174264_eisai_logo-web

Eisai says European Commission backs Halaven to treat of advanced Liposarcoma in Europe

May 5, 2016
Research and Development, Sales and Marketing EC, Eisai, US FDA, oncology, regulation, soft tissue sarcoma

The European Commission has backed marketing for the Japanese drug major Eisai’s (TYO: 4523) Halaven (eribulin) to treat advanced soft …

News
headquarters_3_web

Eli Lilly’s cancer drug candidate scores FDA priority review

May 5, 2016
Eli Lilly, US FDA, oncology, regulation

US drugmaker Eli Lilly (NYSE: LLY) said the US Food and Drug Administration (FDA) has granted priority review for its …

News
brexit

Remaining in the EU is vital for UK’s cancer research strength, say leading oncologists

April 27, 2016
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cancer, EU, Europe, UK, brexit, britain, cancer research, cede, exit, implications, negative, oncology, pharma

Leading UK oncologists have written an article in the May issue of The Lancet, strongly urging Britain to remain in …

News
sample

Merck’s colorectal cancer drug meets primary endpoint in Phase III study

April 25, 2016
Research and Development, Sales and Marketing Erbitux, Merck, Serono, cancer drugs, colorectal cancer, increased survival, oncology, phase 3, phase III

Merck (FWB: MRK) has announced that its Phase III clinical trial of Erbitux, in combination with Folfox, met its primary …

News
bms_building_uk

Bristol-Myers Squibb’s Opdivo shows positive results in early stage trials for advanced skin cancer

April 19, 2016
Manufacturing and Production, Research and Development Bristol-Myers Squibb, drug trial, immuno-therapy, oncology, opdivo

New data for Bristol-Myers Squibb’s (NYSE: BMY) Opdivo to treat advanced melanoma showed overall survival of five years in 34% patients, …

News
opdivo_1

Opdivo shows biggest survival increase for head and neck cancer in 20 years in Phase III trials

April 19, 2016
Research and Development, Sales and Marketing Bristol-Myers Squibb, Cancer, blockbuster, head and neck cancer, nivolumab, oncology, opdivo, potential, squamous

Opdivo (nivolumab) showed the biggest increase in survival for patients with head and neck cancer for 20 years, according to …

News
cancer_cells

Roche’s cholesterol-lowering drug candidate shows promise in fighting prostate cancer

April 15, 2016
Medical Communications, Research and Development RO 48-9071, Roche, cholesterol, drug, missouri, oncology, university

Researchers from the University of Missouri have found that a compound developed by Roche Pharmaceuticals for the treatment of high …

News
mr058666-web

Merck appoints Maya Martinez-Davis as global head of oncology

April 14, 2016
Medical Communications Merck, maya martinez-davis, oncology

Merck has announced the appointment of Maya Martinez-Davis as the new global head of oncology at the German-based company. In …

Appointment
chemo-web

EUSA Pharma acquires global rights to oncology support drug

April 12, 2016
Manufacturing and Production, Research and Development, Sales and Marketing Eusa Pharma, acroral, acroral tab, global rights, oncology

EUSA Pharma has announced the acquisition of global rights to oncology support care product, Arcoral Tab, from Arcoral Pharma.

News
chemo-web

Midatech launch treatment to reduce chemo-induced vomiting in the US

April 11, 2016
Research and Development, Sales and Marketing chemotherapy, midatech, nausea, oncology, radiation, vomiting

Midatech Pharma (NASDAQ: MTP) has the full commercial launch of Zuplenz (ondansetron) in the US. The drug is an oral …

News
Illumina building

Illumina forms spin-off to develop cancer detection test

January 14, 2016
Research and Development Cancer, Illumina, cancer detection, gene sequencing, liquid biospy, oncology

Global gene sequencing company Illumina has won over $100 million in investment from high-profile investors, to create a company “to …

News
MSD logo

MSD to acquire Scottish firm IOmet Pharma

January 12, 2016
Research and Development, Sales and Marketing IOMet Pharma, MSD, Merck, Scotland, acquisitions, immuno-oncology, mergers, oncology

US pharma company MSD is to buy Edinburgh based IOMet Pharma to expand its existing R&D programme, exploring the development …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025